"10.1371_journal.pone.0008533","plos one","2009-12-31T00:00:00Z","Ben D Spycher; Michael Silverman; Juerg Barben; Ernst Eber; St√©phane Guinand; Mark L Levy; Caroline Pao; Willem M van Aalderen; Onno C P van Schayck; Claudia E Kuehni","Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Pulmonology and Allergology, Childrens Hospital St. Gallen, St. Gallen, Switzerland; Respiratory and Allergic Disease Division, Paediatric Department, Medical University of Graz, Graz, Austria; Pulmonology Unit, Department of Paediatrics, Geneva University Hospital, Geneva, Switzerland; Allergy and Respiratory Research Group, Division of Community Health Sciences: GP Section, Edinburgh University, Edinburgh, United Kingdom; Department of Paediatrics, Barts and the London Childrens Hospital, London, United Kingdom; Department of Paediatric Respiratory Medicine and Allergy, Emma Childrens Hospital, Academic Medical Centre, Amsterdam, The Netherlands; Department of General Practice, Maastricht University, Maastricht, The Netherlands","Conceived and designed the experiments: BS MS CEK. Performed the experiments: BS JB EE SG MLL CP WMCvA OCPvS. Analyzed the data: BS. Contributed reagents/materials/analysis tools: BS MS CEK. Wrote the paper: BS MS CEK. Critical review of manuscript: JB EE SG MLL CP WMCvA OCPvS.","Only the authors listed below have potential conflicting interests. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed in the guide for authors http://www.plosone.org/static/policies.action#sharing. Ernst Eber: Dr. Ernst Eber has accepted sponsorship from Abbott, AOP Orphan Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Merck Sharpe and Dohme, Novartis, and Nycomed for attending conferences. He has accepted lecture fees from Abbott, AstraZeneca, Merck Sharpe and Dohme, Novartis, and Nycomed. He has been on advisory boards or provided consultancy for Abbott, AOP Orphan Pharmaceuticals, and Merck Sharp and Dohme. Mark Levy: Dr Mark L. Levy has accepted sponsorship from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Trinity-Cheisi, Merck Sharpe and Dohme, Merck, Altana Pharma, Novartis, Meda Pharmaceuticals, 3M Pharmaceuticals, Schering Plough for attending conferences. He has accepted lecture fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca and Alk-Abello. He has been on advisory boards or provided consultancy for GlaxoSmithKline, Schering Plough, Merck Sharp and Dohme, Trinity-Cheisi, Altana Pharma, Ranbaxy, AstraZeneca, 3M Pharmaceuticals and Novartis. He has had research grants from Boehringer Ingelheim, Pfizer, GSK. He is a member of the ADMIT Group, which receives an unrestricted educational grant from MEDA pharmaceuticals. Caroline Pao: Dr. Caroline Pao has accepted sponsorship from GlaxoSmithKline, Chiesi, Novartis and Forest for attending conferences.","2009","12","Ben D Spycher","BDS",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
